bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.830
+0.020 (2.47%)
Feb 21, 2025, 4:00 PM EST - Market closed
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $12.94 million as of February 21, 2025. Its market cap has decreased by -12.74% in one year.
Market Cap
12.94M
Enterprise Value
13.90M
1-Year Change
-12.74%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $12.94M, a decrease of -71.25%. That is a compound annual growth rate of -39.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 12.94M | -8.79% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 779.78B |
| UnitedHealth Group | 464.28B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 349.35B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Merck & Co. | 217.90B |